Decision-making microRNAs (MIR-124, -133a/b, -34a and -134) in patients with occluded target vessel in acute coronary syndrome

Kardiologia Polska

Volumn 74, Issue 3, 2016, Pages 280-288

  Gacon, Jacek ^a   Kablak Ziembicka, Anna ^b   Stepien, Ewa ^c   Enguita, Francisco J ^d   Karch, Izabela ^b   Derlaga, Boguslaw ^a   Zmudka, Krzysztof ^b   Przewlocki, Tadeusz ^b  

^a Edward Szczeklik Hospital   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Acute coronary syndrome; Infarct related artery; mRNA; NSTEMI; Occluded; STEMI

Indexed keywords

MICRORNA; MICRORNA 124; MICRORNA 133A; MICRORNA 133B; MICRORNA 134; MICRORNA 34A; TROPONIN T; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN124 MICRORNA, HUMAN; MIRN133 MICRORNA, HUMAN; MIRN134 MICRORNA, HUMAN; MIRN34 MICRORNA, HUMAN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; CORONARY ARTERY RECANALIZATION; FEMALE; HUMAN; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RNA EXTRACTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UPREGULATION; BLOOD; COMPLICATION; CORONARY OCCLUSION; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC;

ACUTE CORONARY SYNDROME; ADULT; AGED; BIOMARKERS; CORONARY OCCLUSION; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; ROC CURVE; TROPONIN T;

EID: 84989166243     PISSN: 00229032     EISSN: 18974279     Source Type: Journal    
DOI: 10.5603/KP.a2015.0174     Document Type: Article

References (26)

1. Antman EM. Time is muscle: Translation into practice. J Am Coll Cardiol, 2008; 52: 1216-1221. doi: 10. 1016/j. jacc. 2008. 07. 011.
2. Krishnaswamy A, Lincoff AM, Menon V. Magnitude and consequences of missing the acute infarct-related circumflex artery. Am Heart J, 2009; 158: 706-712. doi:10. 1016/j. Ahj. 2009. 08. 024.
3. Kehl DW, Iqbal N, Fard A et al. Biomarkers in acute myocardial injury. Transl Res, 2012; 159: 252-264. doi: 10. 1016/j. Trsl. 2011. 11. 002.
4. Kablak-Ziembicka A, Przewlocki T, Pieniazek P et al. The role of carotid intima-media thickness assessment in cardiovascular risk evaluation in patients with polyvascular atherosclerosis. Atherosclerosis, 2010; 209: 125-130. doi: 10. 1016/j. Atherosclerosis. 2009. 08. 019.
5. Wang GK, Zhu JQ, Zhang JT et al. Circulating microRNA: A novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J, 2010; 31: 659-666. doi: 10. 1093/eurheartj/ehq013.
6. D'Alessandra Y, Devanna P, Limana F et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J, 2010; 31: 2765-2773. doi: 10. 1093/eurheartj/ehq167.
7. Orenes-Piñero E, Montoro-García S, Patel JV et al. Role of microRNAs in cardiac remodelling: new insights and future perspectives. Int J Cardiol, 2013; 167: 1651-1659. doi: 10. 1016/j. ijcard. 2012. 09. 120.
8. Widera C, Gupta SK, Lorenzen JM et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol, 2011; 51: 872-875. doi: 10. 1016/j. yjmcc. 2011. 07. 011.
9. Oerlemans MI, Mosterd A, Dekker MS et al. Early assessment of acute coronary syndromes in the emergency department: The potential diagnostic value of circulating microRNAs. EMBO Mol Med, 2012; 4: 1176-1185. doi: 10. 1002/emmm. 201201749.
10. Song J, Bai Z, Han W et al. Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci, 2012; 57: 897-904. doi: 10. 1007/s10620-011-1981-7.
11. de Hoon MJL, Imoto S, Nolan J, Miyano S. Open Source Clustering Software. Bioinformatics 2004; 20: 1453-1454. doi: 10. 1093/bioinformatics/ bth078
12. Devaux Y, Vausort M, McCann GP et al. A panel of 4 microRNAs facilitates the prediction of left ventricular contractility after acute myocardial infarction. PLoS One, 2013; 8: e70644. doi: 10. 1371/journal. pone. 0070644.
13. Eitel I, Adams V, Dieterich P et al. Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction. Am Heart J, 2012; 164: 706-714. doi: 10. 1016/j. Ahj. 2012. 08. 004.
14. Corsten MF, Dennert R, Jochems S et al. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet, 2010; 3: 499-506. doi: 10. 1161/CIRCGENETICS. 110. 957415.
15. D'Alessandra Y, Carena MC, Spazzafumo L et al. Diagnostic potential of plasmatic MicroRNA signatures in stable and unstable angina. PLoS One, 2013; 8: e80345. doi: 10. 1371/journal. pone. 0080345.
16. Andersson P, Gidlöf O, Braun OO et al. Plasma levels of liver-specific miR-122 is massively increased in a porcine cardiogenic shock model and attenuated by hypothermia. Shock, 2012; 37: 234-238. doi: 10. 1097/SHK. 0b013e31823f1811.
17. Fan F, Sun A, Zhao H et al. MicroRNA-34a promotes cardiomyocyte apoptosis post myocardial infarction through down-regulating aldehyde dehydrogenase 2. Curr Pharm Des, 2013; 19: 4865-4873. doi: 10. 2174/13816128113199990325.
18. Cao L, Kong LP, Yu ZB et al. MicroRNA expression profiling of the developing mouse heart. Int J Mol Med, 2012; 30: 1095-1104. doi: 10. 3892/ijmm. 2012. 1092.
19. De Rosa S, Fichtlscherer S, Lehmann R et al., Transcoronary concentration gradients of circulating microRNAs. Circulation, 2011; 124: 1936-1944. doi: 10. 1161/CIRCULATIONAHA. 111. 037572.
20. Sonntag KC, Woo TUW, Krichevsky AM. Converging miRNA functions in diverse brain disorders: A case for miR-124 and miR-126. Exp Neurol, 2012, 235: 427-435. doi: 10. 1016/j. expneurol. 2011. 11. 035.
21. Boon RA, Iekushi K, Lechner S et al. MicroRNA-34a regulates cardiac ageing and function. Nature, 2013; 495: 107-110. doi: 10. 1038/nature11919.
22. Hoekstra M1, van der Lans CA, Halvorsen B et al. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun, 2010; 394: 792-797. doi: 10. 1016/j. bbrc. 2010. 03. 075.
23. Du L, Pertsemlidis A. Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation. J Mol Cell Biol, 2011; 3: 176-180. doi: 10. 1093/jmcb/mjq058.
24. He F, Lv P, Zhao X et al. Predictive value of circulating miR-328 and miR-134 for acute myocardial infarction. Mol Cell Biochem, 2014; 394: 137-144. doi: 10. 1007/s11010-014-2089-0.
25. Gidlöf O, Andersson P, van der Pals J et al. Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology, 2011; 118: 217-226. doi:10. 1159/000328869.
26. Goretti E, Vausort M, Wagner DR, Devaux Y. Association between circulating microRNAs, cardiovascular risk factors and outcome in patients with acute myocardial infarction. Int J Cardiol, 2013; 168: 4548-4550. doi: 10. 1016/j. ijcard. 2013. 06. 092